Chung & Liao (388) reported that CXCR3 signaling in glial cells mitigates experimental autoimmune encephalomyelitis by limiting the development of a pro-Th17 cytokine environment and decreasing the infiltration of Th17 cells into the CNS. This evidence concerns the gene CXCR3 and experimental autoimmune encephalomyelitis.